| 000 | 01796 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515074358.0 | ||
| 264 | 0 | _c20071214 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2007.03384.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGisbert, J P | |
| 245 | 0 | 0 |
_aFirst-line triple therapy with levofloxacin for Helicobacter pylori eradication. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cAug 2007 |
||
| 300 |
_a495-500 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBismuth _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
| 650 | 0 | 4 | _aHelicobacter pylori |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLevofloxacin |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOfloxacin _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRanitidine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFernández-Bermejo, M | |
| 700 | 1 | _aMolina-Infante, J | |
| 700 | 1 | _aPérez-Gallardo, B | |
| 700 | 1 | _aPrieto-Bermejo, A-B | |
| 700 | 1 | _aMateos-Rodríguez, J-M | |
| 700 | 1 | _aRobledo-Andrés, P | |
| 700 | 1 | _aGonzález-García, G | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 26 _gno. 3 _gp. 495-500 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2007.03384.x _zAvailable from publisher's website |
| 999 |
_c17169939 _d17169939 |
||